Compare · AGL vs LSTA
AGL vs LSTA
Side-by-side comparison of agilon health inc. (AGL) and Lisata Therapeutics Inc. (LSTA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AGL and LSTA operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- AGL is the larger of the two at $1.49B, about 128.5x LSTA ($11.6M).
- LSTA has been more active in the news (9 items in the past 4 weeks vs 2 for AGL).
- AGL has more recent analyst coverage (25 ratings vs 0 for LSTA).
- Company
- agilon health inc.
- Lisata Therapeutics Inc.
- Price
- -
- -
- Market cap
- $1.49B
- $11.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 2
- 9
- Recent ratings
- 25
- 0
AGL
agilon health inc.
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Long Beach, California.
Latest AGL
- agilon health Sets Date to Report Third Quarter 2026 Financial Results
- agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO
- agilon health and Springfield Clinic Broaden Partnership Through Senior Health Connect ACO
- agilon health upgraded by Bernstein with a new price target
- agilon health and Family Practice Center Expand Relationship Through Senior Health Connect ACO
- agilon health Announces Revised Presentation Time at the 2026 Jefferies Healthcare Services and Technology Conference
- agilon health to Participate in Upcoming Conferences
- Chief Accounting Officer Gertsch Timothy covered exercise/tax liability with 17 shares, decreasing direct ownership by 0.12% to 14,152 units (SEC Form 4) (withholding tax)
- Amendment: SEC Form SCHEDULE 13G/A filed by agilon health inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by agilon health inc.
Latest LSTA
- SEC Form 3 filed by Lisata Therapeutics Inc.
- SEC Form 8-K filed by Lisata Therapeutics Inc.
- Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
- Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors
- SEC Form PRE 14A filed by Lisata Therapeutics Inc.
- Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly
- SEC Form D filed by Lisata Therapeutics Inc.
- New insider Love Ted W claimed ownership of 19,260 shares (SEC Form 3)
- New insider Lehrer-Graiwer Joshua claimed ownership of 27,808 shares (SEC Form 3)
- Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026